JPRN-UMIN000044369
Completed
未知
A pilot study to evaluate the efficacy of personal health record to healthcare quality in cardiovascular disease patients with lifestyle diseases - PHRASAL Pilot Study
Japan Agency for Medical Research and Development (AMED)0 sites200 target enrollmentJune 1, 2021
ConditionsCardiovascular disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Cardiovascular disease
- Sponsor
- Japan Agency for Medical Research and Development (AMED)
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who do not give written informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Personalized treatment of rectal cancer with induction chemotherapy, radiation therapy and consolidation chemotherapyRectal cancerD012004JPRN-jRCTs021210076Miura Takuya40
Active, not recruiting
Phase 1
Study to evaluate the efficacy of OnabotulinumtoxinA in migraineEUCTR2017-002866-38-ITIRCCS FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE C. MONDINO42
Completed
Phase 2
The IMPACT trial: Individualised Molecular Pancreatic Cancer Therapy; a phase II trial assessing feasibility of personalised treatment based on specified tumour molecular signatures (phenotypes) of the tumour in patients with recurrent or metastatic pancreatic cancer.Advanced (metastatic or recurrent) pancreatic cancerCancer - PancreaticACTRN12612000777897The Australasian Gastro-Intestinal Trials Group (AGITG)10
Active, not recruiting
Not Applicable
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]Non Familial Chylomicronemia Syndrome (Non-FCS)EUCTR2012-000872-40-CZovartis Pharma Services AG60
Completed
Phase 3
A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.preterm infantsJPRN-UMIN000015061agano Children's Hospital10